These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26388694)

  • 1. Thyroid transcription factor-1 expression is significantly associated with mutations in exon 21 of the epidermal growth factor receptor gene in Chinese patients with lung adenocarcinoma.
    Zhao Q; Xu S; Liu J; Li Y; Fan Y; Shi T; Wei S; Tang SC; Liu H; Chen J
    Onco Targets Ther; 2015; 8():2469-78. PubMed ID: 26388694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid transcription factor-1 as a prognostic indicator for stage IV lung adenocarcinoma with and without EGFR-sensitizing mutations.
    Park JY; Jang SH; Kim HI; Kim JH; Park S; Hwang YI; Jung KS; Seo J; Lee CY; Ko Y; Park YB
    BMC Cancer; 2019 Jun; 19(1):574. PubMed ID: 31196060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor (EGFR) mutations are exceptionally rare in thyroid transcription factor (TTF-1)-negative adenocarcinomas of the lung.
    Somaiah N; Fidler MJ; Garrett-Mayer E; Wahlquist A; Shirai K; Buckingham L; Hensing T; Bonomi P; Simon GR
    Oncoscience; 2014; 1(8):522-528. PubMed ID: 25594059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment.
    Chung KP; Huang YT; Chang YL; Yu CJ; Yang CH; Chang YC; Shih JY; Yang PC
    Chest; 2012 Feb; 141(2):420-428. PubMed ID: 21799026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TTF-1 and EGFR expression are related to EGFR mutation in lung adenocarcinoma.
    Chen C; Shen D; Li J; Sun Y; Wang J
    Int J Clin Exp Pathol; 2018; 11(9):4650-4656. PubMed ID: 31949865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between TTF-1 expression and EGFR mutations in lung adenocarcinomas.
    Shanzhi W; Yiping H; Ling H; Jianming Z; Qiang L
    PLoS One; 2014; 9(4):e95479. PubMed ID: 24743427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
    Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
    J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations.
    Zhang R; Li Y; Nie X; Dong X; Wu G
    Onco Targets Ther; 2016; 9():355-66. PubMed ID: 26848271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia.
    Piljić Burazer M; Mladinov S; Ćapkun V; Kuret S; Glavina Durdov M
    Med Sci Monit; 2017 Jan; 23():489-497. PubMed ID: 28128193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thyroid transcription factor-1 level is associated with epidermal growth factor receptor mutation status in patients with advanced lung adenocarcinoma].
    Niu Y; Wang H; Zhang G; Ma J; Wei B; Ma Z
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Dec; 37(12):919-23. PubMed ID: 25609130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of TTF-1 immunoexpression and EGFR mutation spectrum in non-small cell lung carcinoma.
    Nakra T; Singh V; Nambirajan A; Malik PS; Mohan A; Jain D
    J Pathol Transl Med; 2021 Jul; 55(4):279-288. PubMed ID: 34233113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid transcription factor 1 (TTF-1) negativity as a predictor of unfavorable response to EGFR-TKI therapy in advanced lung adenocarcinoma patients with EGFR mutations.
    Ding X; Shi W; Han B; Chen H; Li J; An J; Zhou L; Xu W; Shi H; Zheng X; Hua Y; Li X
    Thorac Cancer; 2023 Oct; 14(29):2934-2940. PubMed ID: 37605791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-terminal respiratory unit type lung adenocarcinoma has three distinct subtypes and is associated with poor prognosis.
    Sumiyoshi S; Yoshizawa A; Sonobe M; Kobayashi M; Sato M; Fujimoto M; Tsuruyama T; Date H; Haga H
    Lung Cancer; 2014 Jun; 84(3):281-8. PubMed ID: 24725383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic role of thyroid transcription factor-1 in lung adenocarcinoma.
    Oktay E; Oflazoglu U; Varol Y; Tanriverdi O; Mermur N; Arda HU; Demir L; Keskin O; Ahmadli T; Somali I; Oztop I; Meydan N
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S1201-S1208. PubMed ID: 30539871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].
    Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic role of thyroid transcription factor-1 in lung adenocarcinoma.
    Oktay E; Oflazoglu U; Varol Y; Tanriverdi O; Mermur N; Arda HU; Demir L; Keskin O; Ahmadli T; Somali I; Oztop I; Meydan N
    J Cancer Res Ther; 2020; 16(4):737-744. PubMed ID: 32930112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of thyroid transcription factor-1 and HER2/neu in non-small cell lung cancer: strong thyroid transcription factor-1 expression predicts better survival.
    Haque AK; Syed S; Lele SM; Freeman DH; Adegboyega PA
    Appl Immunohistochem Mol Morphol; 2002 Jun; 10(2):103-9. PubMed ID: 12051626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.
    Rossi G; Cavazza A; Righi L; Sartori G; Bisagni A; Longo L; Pelosi G; Papotti M
    Int J Surg Pathol; 2014 Aug; 22(5):401-7. PubMed ID: 24651909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetic alterations in thyroid transcription factor 1-negative lung adenocarcinoma in cytology specimens: A subset with aggressive behavior and a poor prognosis.
    Rodriguez EF; VandenBussche CJ; Chowsilpa S; Maleki Z
    Cancer Cytopathol; 2018 Oct; 126(10):853-859. PubMed ID: 30199148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR and TTF-1 gene amplification in surgically resected lung adenocarcinomas: clinicopathologic significance and effect on response to EGFR-tyrosine kinase inhibitors in recurred cases.
    Lee JS; Kim HR; Lee CY; Shin M; Shim HS
    Ann Surg Oncol; 2013 Sep; 20(9):3015-22. PubMed ID: 23525704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.